Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.340 | 0.500 | 0.160 |
Shares | 99.660 | 99.660 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.874 | 19.348 |
Price to Book | 2.993 | 4.050 |
Price to Sales | 3.711 | 5.381 |
Price to Cash Flow | 14.221 | 15.826 |
Dividend Yield | 1.118 | 0.512 |
5 Years Earnings Growth | 7.588 | 25.708 |
Number of long holdings: 106
Number of short holdings: 25
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Alnylam | US02043Q1076 | 3.31 | 251.41 | -0.77% | |
Vertex | US92532F1003 | 3.18 | 467.33 | +0.06% | |
Amgen | US0311621009 | 3.12 | 279.66 | -0.13% | |
Novartis | CH0012005267 | 3.08 | 92.75 | +0.89% | |
Biomarin Pharma | US09061G1013 | 3.04 | 64.89 | +0.01% | |
Ionis Pharma | US4622221004 | 3.02 | 36.17 | +2.26% | |
Gilead | US3755581036 | 3.02 | 92.80 | +1.58% | |
Biogen | US09062X1037 | 2.97 | 160.29 | +1.65% | |
Roche Holding Participation | CH0012032048 | 2.96 | 252.50 | +0.44% | |
Crispr Therapeutics | CH0334081137 | 2.91 | 50.74 | +2.90% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPI Global Income Fund A acc USD he | 17.91B | 9.76 | 2.45 | 4.17 | ||
JPI Global Income Fund A div USD he | 17.91B | 9.78 | 2.47 | 4.18 | ||
JPI Global Income Fund A mth USD he | 17.91B | 9.75 | 2.44 | 4.16 | ||
JPI Global Income Fund C acc USD he | 17.91B | 10.32 | 3.13 | 4.86 | ||
JPI Global Income Fund C dist USD h | 17.91B | 10.31 | 3.12 | 4.85 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review